Find where to buy products from UK suppliers, including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
Search for products or services, then visit the suppliers website for prices, SDS or more information. You can also view suppliers in Australia, NZ or the USA.
| Product | Description | |
|---|---|---|
| Oxaliplatin | 1g Pack Size. Group: Bioactive Small Molecules, Research Organics & Inorganics. Formula: C8H14N2O4Pt C8H14N2O4Pt. CAS No. 61825-94-3. Prepack ID : 27659030-1g. Molecular Weight : 397.29. |  |
| Oxaliplatin | 250mg Pack Size. Group: Bioactive Small Molecules, Research Organics & Inorganics. Formula: C8H14N2O4Pt C8H14N2O4Pt. CAS No. 61825-94-3. Prepack ID : 27659030-250mg. Molecular Weight : 397.29. | |
| Oxaliplatin | Oxaliplatin is a platinum-based antineoplastic agent used in cancer chemotherapy that inhibits DNA synthesis by conforming DNA adducts in cancer cells. Group: Pharmaceutical. CAS No. 61825-94-3. Pack Sizes: 500 mg. Product ID: B0084-095706. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| Oxaliplatin Impurities | Oxaliplatin Impurities are integral to the stringent quality control processes employed during the pharmaceutical manufacturing of the drug, pivotal for its efficacy in colorectal cancer treatment. These impurities' meticulous monitoring is critical for preserving oxaliplatin's therapeutic integrity, a chemotherapeutic cornerstone known for its exceptional antitumor efficacy. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Satraplatin | Satraplatin, also known as JM216, is a platinum compound that is currently under investigation as one treatment of patients with advanced prostate cancer who have failed previous chemotherapy. It has not yet received approval from the U.S. Food and Drug Administration. First mentioned in the medical literature in 1993, satraplatin is the first orally active platinum-based chemotherapeutic drug; other available platinum analogues-cisplatin, carboplatin, and oxaliplatin-must be given intravenously. It is made available in the United States jointly by Spectrum Pharmaceuticals and GPC Biotech under the name SPERA (Satraplatin Expanded Rapid Access). The drug has also been used in the treatment of lung and ovarian cancers. The proposed mode of action is that the compound binds to the DNA of cancer cells rendering them incapable of dividing. Group: Pharmaceutical. CAS No. 129580-63-8. Pack Sizes: 50 mg. Product ID: B0084-056858. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Veliparib | Veliparib (ABT-888) is a potent inhibitor of PARP1 and PARP2 with Ki of 5.2 nM and 2.9 nM, respectively. In HCT-116 and HT-29 cell lines, the ability of ABT-888 to synergize the effect of the anti-cancer agents, SN38 or oxaliplatin, was determined using the SRB assay. PARP activity was significantly reduced in samples treated with SN38 in combination with ABT-888 (>4 fold at 24 h). Uses: For research used only. Group: Pharmaceutical. CAS No. 912444-00-9. Pack Sizes: 250 mg. Product ID: B0084-079466. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Our database is helping our users find suppliers everyday.
